The role of tissue and liquid biopsies in managing colorectal cancer

Alberto Sobrero, MD, IRCCS Ospedale San Martino IST, Genoa, Italy, provides an overview of the current uses of tissue and liquid biopsies for the management of colorectal cancer. Whilst biopsies have prognostic value, they have also been used in the predicative setting. For patients who remain circulating tumor DNA (ctDNA)-positive after adjuvant treatment, relapse-free survival is found to be lower than in patients who become ctDNA-negative. This interview took place at the ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023 in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.